What is NDC 71610-741?

71610-741 is the product NDC for Lisinopril, Lisinopril 2.5 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 7 package NDCs, shown above in 10- and 11-digit form.

Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lisinopril?

258 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lisinopril NDC 71610-741 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71610-741Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71610-0741Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71610-741-30	71610074130	30 TABLET in 1 BOTTLE (71610-741-30)Marketed from Oct 3, 2023
71610-741-45	71610074145	45 TABLET in 1 BOTTLE (71610-741-45)Marketed from Oct 3, 2023
71610-741-53	71610074153	60 TABLET in 1 BOTTLE (71610-741-53)Marketed from Oct 3, 2023
71610-741-60	71610074160	90 TABLET in 1 BOTTLE (71610-741-60)Marketed from Oct 3, 2023
71610-741-70	71610074170	120 TABLET in 1 BOTTLE (71610-741-70)Marketed from Oct 3, 2023
71610-741-75	71610074175	150 TABLET in 1 BOTTLE (71610-741-75)Marketed from Oct 3, 2023
71610-741-80	71610074180	180 TABLET in 1 BOTTLE (71610-741-80)Marketed from Oct 3, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lisinopril
Generic name (nonproprietary): lisinopril
Active ingredients: Lisinopril — 2.5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aphena Pharma Solutions - Tennessee, LLCNDC labeler code 71610
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 075743
Marketing start: Aug 30, 2017
Listing expires: Dec 31, 2026
Other FDA classes: Angiotensin-converting Enzyme Inhibitors (Mechanism)
Identifiers: Product ID 71610-741_9f5db76f-349d-4856-b7d9-ded1ab8ca656SPL ID 9f5db76f-349d-4856-b7d9-ded1ab8ca656SPL set ID a79a034d-7bbb-4b05-b8fc-8ebf09f33c0cRxCUI 311353UNII E7199S1YWR
Pharmacologic class: Angiotensin Converting Enzyme Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471610074130 followed by a unit qualifier and the quantity

Package 71610-0741-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 4, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Lisinopril is an angiotensin converting enzyme (ACE) inhibitor indicated for: • Treatment of hypertension in adults and pediatric patients 6 years of age and older (1.1) • Adjunct therapy for heart failure (1.2) • Treatment of Acute Myocardial Infarction (1.3) 1.1 Hypertension Lisinopril tablets are indicated for the treatment of hypertension in adult patients and pediatric patients 6 years of age and older to lower blood pressure. Lowering blood pressure lowers the risk of fatal and non-fatal cardiovascular events, primarily strokes and myocardial infarctions. These benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes. Control o…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71610-741

What is NDC 71610-741?: 71610-741 is the product NDC for Lisinopril, Lisinopril 2.5 mg/1 tablet, listed with the FDA by Aphena Pharma Solutions - Tennessee, LLC. It has 7 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lisinopril.
What is the active ingredient?: Lisinopril.
Who is the labeler?: Aphena Pharma Solutions - Tennessee, LLC, NDC labeler code 71610. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lisinopril?: 258 other product NDCs are listed under this name. See all Lisinopril NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lisinopril NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lisinopril	Lisinopril 5 mg/1	TabletOral	Coupler LLC	67046-2097	67046-2097-03
Lisinopril	Lisinopril 10 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-047	87441-0047-01
Lisinopril	Lisinopril 20 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-048	87441-0048-01
Lisinopril	Lisinopril 5 mg/1	TabletOral	Unit Dose Solutions, Inc.	87441-049	87441-0049-01
Lisinopril	Lisinopril 10 mg/1	TabletOral	Coupler LLC	67046-0422	67046-0422-03
Lisinopril	Lisinopril 20 mg/1	TabletOral	Coupler LLC	67046-0423	67046-0423-03
Lisinopril	Lisinopril 5 mg/1	TabletOral	Coupler LLC	67046-0858	67046-0858-03
lisinopril	Lisinopril 10 mg/1	TabletOral	REMEDYREPACK INC.	70518-4509	70518-4509-00
Lisinopril	Lisinopril 10 mg/1	TabletOral	REMEDYREPACK INC.	70518-4397	70518-4397-00
Lisinopril	Lisinopril 5 mg/1	TabletOral	Preferred Pharmaceuticals Inc.	68788-8562	68788-8562-0168788-8562-0368788-8562-06+1 more

All 259 Lisinopril NDCs

Other NDCs under ANDA 075743

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075743
Product	Strength	Form · route	Labeler	Product NDC
Lisinopril	Lisinopril 2.5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-810
Lisinopril	Lisinopril 5 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-811
Lisinopril	Lisinopril 10 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-812
Lisinopril	Lisinopril 20 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-813
Lisinopril	Lisinopril 30 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-814
Lisinopril	Lisinopril 40 mg/1	TabletOral	PD-Rx Pharmaceuticals, Inc.	43063-815
Lisinopril	Lisinopril 2.5 mg/1	TabletOral	Solco healthcare U.S., LLC	43547-414
Lisinopril	Lisinopril 5 mg/1	TabletOral	Solco healthcare U.S., LLC	43547-415
Lisinopril	Lisinopril 10 mg/1	TabletOral	Solco healthcare U.S., LLC	43547-416
Lisinopril	Lisinopril 20 mg/1	TabletOral	Solco healthcare U.S., LLC	43547-417
Lisinopril	Lisinopril 30 mg/1	TabletOral	Solco healthcare U.S., LLC	43547-418
Lisinopril	Lisinopril 40 mg/1	TabletOral	Solco healthcare U.S., LLC	43547-419
Lisinopril	Lisinopril 40 mg/1	TabletOral	Aphena Pharma Solutions - Tennessee, LLC	71610-406